Pharmacological management of fluid overload

British Journal of Anaesthesia

Volumn 113, Issue 5, 2014, Pages 756-763

  Goldstein, S ^a   Bagshaw, S ^b   Cecconi, M ^c   Okusa, M ^d   Wang, H ^e   Kellum, J ^f   Mythen, M ^g   Shaw, A D ^h  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

acute kidney injury; fluid overload; medications

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANGIOTENSIN II; DOPAMINE; FENOLDOPAM; FUROSEMIDE; HYPERTENSIVE FACTOR; LOOP DIURETIC AGENT; NATRIURETIC FACTOR; SERUM ALBUMIN; VASOPRESSIN; DIURETIC AGENT;

ACUTE HEART FAILURE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL DECISION MAKING; CRITICALLY ILL PATIENT; DIURETIC THERAPY; FLUID BALANCE; FLUID RESUSCITATION; HUMAN; HYPERVOLEMIA; HYPOVOLEMIC SHOCK; KIDNEY DISTAL TUBULE; KIDNEY FUNCTION; MEDICATION THERAPY MANAGEMENT; ONCOTIC PRESSURE; RISK FACTOR; TREATMENT OUTCOME; URINE VOLUME; DELPHI STUDY; FLUID THERAPY; HEART FAILURE; INTENSIVE CARE; PERFUSION; RESUSCITATION; SHOCK; WATER-ELECTROLYTE IMBALANCE;

CRITICAL CARE; DELPHI TECHNIQUE; DIURETICS; FLUID THERAPY; HEART FAILURE; HUMANS; PERFUSION; RESUSCITATION; SHOCK; WATER-ELECTROLYTE IMBALANCE;

EID: 84911042032     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu299     Document Type: Article

References (68)

1. de Oliveira CF, de Oliveira DS, Gottschald AF, et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med 2008; 34: 1065-75
2. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77
3. Townsend SR, Schorr C, Levy MM, Dellinger RP. Reducing mortality in severe sepsis: the Surviving Sepsis Campaign. Clin Chest Med 2008; 29: 721-33, x
4. Goldstein SL. Fluid management in acute kidney injury. J Intensive Care Med 2012; 29: 183-9
5. Arikan AA, Zappitelli M, Goldstein SL, Naipaul A, Jefferson LS, Loftis LL. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med 2012; 13: 253-8
6. Goldstein SL, Currier H, Graf C, Cosio CC, Brewer ED, Sachdeva R. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001; 107: 1309-12
7. Goldstein SL, Somers MJ, Baum MA, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67: 653-8
8. Sutherland SM, Zappitelli M, Alexander SR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010; 55: 316-25
9. Selewski DT, Cornell TT, Lombel RM, et al. Weight-based determination of fluid overload status and mortality in pediatric intensive care unit patients requiring continuous renal replacement therapy. Intensive Care Med 2011; 37: 1166-73
10. Valentine SL, Sapru A, Higgerson RA, et al. Fluid balance in critically ill children with acute lung injury. Crit Care Med 2012; 40: 2883-9
11. Hazle MA, Gajarski RJ, Yu S, Donohue J, Blatt NB. Fluid overload in infants following congenital heart surgery. Pediatr Crit Care Med 2013; 14: 44-9
12. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009; 76: 422-7
13. PayenD, de PontAC, Sakr Y, Spies C,Reinhart K, Vincent JL.Apositive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12: R74
14. Murphy CV, Schramm GE, Doherty JA, et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009; 136: 102-9
15. Heung M,WolfgramDF, Kommareddi M, Hu Y, Song PX, OjoAO. Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrol Dial Transplant 2012; 27: 956-61
16. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved outcomebasedon fluidmanagement in critically ill patients requiring pulmonary artery catheterization.Am Rev Respir Dis 1992; 145: 990-8
17. Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6: 966-73
18. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-75
19. Ronco C, Kellum JA, Mehta R. Acute dialysis quality initiative (ADQI). Nephrol Dial Transplant 2001; 16: 1555-8
20. Van BiesenW, Yegenaga I, Vanholder R, et al. Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J Nephrol 2005; 18: 54-60
21. Shilliday IR,Quinn KJ, Allison ME. Loop diuretics in themanagement of acute renal failure: a prospective, double-blind, placebocontrolled, randomized study. Nephrol Dial Transplant 1997; 12: 2592-6
22. Mehta RL, Pascual MT, Soroko S, Chertow GM, Group PS. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. J Am Med Assoc 2002; 288: 2547-53
23. Chawla LS, Davison DL, Brasha-Mitchell E, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 2013; 17: R207
24. Bagshaw SM, Brophy PD, Cruz D, Ronco C. Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care 2008; 12: 169
25. Raghunathan K, ShawAD, BagshawSM. Fluids are drugs: type, dose and toxicity. Curr Opin Crit Care 2013; 19: 290-8
26. Pan SW, Kao HK, Lien TC, Chen YW, Kou YR,Wang JH. Acute kidney injuryon ventilator initiation day independently predicts prolonged mechanical ventilation in intensive care unit patients. J Crit Care 2011; 26: 586-92
27. Vieira JM Jr, Castro I, Curvello-Neto A, et al. Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients. Crit Care Med 2007; 35: 184-91
28. Brandstrup B, Tonnesen H, Beier-Holgersen R, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003; 238: 641-8
29. Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactateguided therapy in intensive care unit patients: a multicenter, openlabel, randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 752-61
30. Boyd JH, Forbes J, Nakada TA,Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39: 259-65
31. Goldstein SL. Use of biomarkers to optimize fluid dosing, CRRT initiation and discontinuation in pediatric ICU patients with AKI (taking focus). ClinicalTrials.gov, 2012
32. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med 2006; 34: 1333-7
33. Cecconi M, Parsons AK, Rhodes A. What is a fluid challenge?. Curr Opin Crit Care 2011; 17: 290-5
34. Shoemaker WC, Appel PL, Kram HB,Waxman K, Lee TS. Prospective trial of supranormalvalues of survivors astherapeutic goals in highrisk surgical patients. Chest 1988; 94: 1176-86
35. Rhodes A, Cecconi M, Hamilton M, et al. Goal-directed therapy in high-risk surgical patients: a 15-year follow-up study. Intensive Care Med 2010; 36: 1327-32
36. Cecconi M, Corredor C, Arulkumaran N, et al. Clinical review: goaldirected therapy-what is the evidence in surgical patients?. The effect on different risk groups. Crit Care 2013; 17: 209
37. Brater DC. Diuretic therapy. N Engl J Med 1998; 339: 387-95
38. Kirchner KA, Voelker JR, Brater DC. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome. J Pharmacol Exp Ther 1990; 252: 1097-101
39. Inoue M, Okajima K, Itoh K, et al. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 1987; 32: 198-203
40. Elwell RJ, Spencer AP, Eisele G. Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 2003; 37: 695-700
41. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40: 632-42
42. Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL, High- Dose Flurosemide in Acute Renal Failure Study G. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004; 44: 402-9
43. van der Voort PH, Boerma EC, Koopmans M, et al. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med 2009; 37: 533-8
44. Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure. A controlled trial. Nephron 1976; 17: 51-8
45. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. J Am Med Assoc 2005; 294: 813-8
46. Grams ME, Estrella MM, Coresh J, et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6: 966-73
47. BagshawSM, Gibney RT, McAlister FA, Bellomo R. The SPARKStudy: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury. Trials 2010; 11: 50
48. Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001; 96: 132-43
49. vanMeyel JJ, Smits P, Russel FG, Gerlag PG, Tan Y, Gribnau FW. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther 1992; 51: 440-4
50. Copeland JG, Campbell DW, Plachetka JR, Salomon NW, Larson DF. Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg 1983; 146: 796-9
51. Rudy DW, Voelker JR, Greene PK, Esparza FA, Brater DC. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991; 115: 360-6
52. Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364: 797-805
53. Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2004: CD003178
54. Ellison DH, Velazquez H, Wright FS. Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 1989; 83: 113-26
55. Morsing P, Velazquez H, Wright FS, Ellison DH. Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion. Am J Physiol 1991; 261: F137-43
56. Ng TM, Konopka E, Hyderi AF, et al. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. J Cardiovasc Pharmacol Ther 2013; 18: 345-53
57. Kiyingi A, Field MJ, Pawsey CC, Yiannikas J, Lawrence JR, Arter WJ. Metolazone in treatment of severe refractory congestive cardiac failure. Lancet 1990; 335: 29-31
58. Lauschke A, Teichgraber UK, Frei U, Eckardt KU. "Low-dose dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006; 69: 1669-74
59. Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail 2010; 16: 922-30
60. Tumlin JA, Wang A, Murray PT, Mathur VS. Fenoldopam mesylate blocks reductions in renal plasmaflowafter radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J 2002; 143: 894-903
61. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. J Am Med Assoc 2003; 290: 2284-91
62. Ricci Z, Luciano R, Favia I, et al. High-dosefenoldopamreducespostoperative neutrophil gelatinase-Associated lipocaline and cystatin C levels in pediatric cardiac surgery. Crit Care 2011; 15: R160
63. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metabol1993; 76: 91-6
64. van der Zander K, Houben AJ, Hofstra L, Kroon AA, de Leeuw PW. Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study. Am J Physiol Heart Circ Physiol 2003; 285: H1206-12
65. Yancy CW, Krum H, Massie BM, et al. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Circulation Heart Fail 2008; 1: 9-16
66. Gottlieb SS, Stebbins A, Voors AA, et al. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure). J Am Coll Cardiol 2013; 62: 1177-83
67. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. J Am Med Assoc 2007; 297: 1319-31
68. Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol 2007; 156: 236-49